478 reports of this reaction
3.7% of all SCOPOLAMINE reports
#3 most reported adverse reaction
VOMITING is the #3 most commonly reported adverse reaction for SCOPOLAMINE, manufactured by Baxter Healthcare Corporation. There are 478 FDA adverse event reports linking SCOPOLAMINE to VOMITING. This represents approximately 3.7% of all 12,807 adverse event reports for this drug.
Patients taking SCOPOLAMINE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is moderately reported among SCOPOLAMINE users, representing a notable but not dominant share of adverse events.
In addition to vomiting, the following adverse reactions have been reported for SCOPOLAMINE:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 478 FDA reports for SCOPOLAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 3.7% of all adverse event reports for SCOPOLAMINE, making it one of the most commonly reported side effect.
If you experience vomiting while taking SCOPOLAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.